Davis Polk advised the sales agent, Jefferies, in the transaction. Affimed N.V. established its at-the-market offering program of up to $100 million gross sales price of its common...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent on the deal. Inventiva S.A., a clinical-stage biotechnological company, announced the implementation of an At-The-Market (“ATM”) program allowing the Company to...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell represented the underwriters in the offering Maravai LifeSciences Holdings, Inc. annunced the $1 billion secondary offering of 20,000,000 shares of Class A common...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers and representatives of the other underwriters in the offering. Eli Lilly and Company executed the offering of €600 million aggregate...
You must be a Standard 1 Year member to access this content.
Winston & Strawn represented Norwest Equity Partners in the transaction. Norwest Equity Partners (“NEP”), a leading middle-market investment firm founded in 1961, completed the sale of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Adagio Therapeutics, Inc. executed the initial public offering of 20,930,000 shares of its common stock at...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. RxSight, Inc. executed an initial public offering of 7,350,000 shares of common stock at $16.00 per...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering while Wilson Sonsini Goodrich & Rosati represented Tenaya Therapeutics. Tenaya Therapeutics, Inc. executed the initial...
You must be a Standard 1 Year member to access this content.
Homburger and Davis Polk advised SOPHiA GENETICS on the deal. Lenz & Staehelin acted as Swiss counsel to the underwriters. SOPHiA GENETICS SA listed its shares...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Acutus Medical on the deal. Acutus Medical, Inc. executed its SEC-registered public offering of 5,500,000 shares of common stock for an aggregate price...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Sight Sciences, Inc. in the offering, while Davis Polk advised the representatives of the several underwriters. Sight Sciences, Inc. executed its initial public...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised IDEAYA Biosciences, while Davis Polk advised the underwriters in the offering. IDEAYA Biosciences, Inc. executed its public offering of 5,333,333 shares of common...
You must be a Standard 1 Year member to access this content.
